Recommendations for Preclinical Research in Hemorrhagic Transformation

Susan C. Fagan, Paul A. Lapchak, David S. Liebeskind, Tauheed Ishrat, Adviye Ergul

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Hemorrhagic transformation (HT) is an important complication of ischemic stroke and is responsible for most of the mortality associated with acute reperfusion therapy. Although many important publications address the preclinical models of ischemic stroke, there are no current recommendations on the conduct of research aimed at understanding the mechanisms and consequences of HT. The purpose of this review is to present the various models used in HT research, the clinical correlates, and the experimental variables known to influence the quantitation of HT in preclinical investigation. Lastly, recommendations for the conduct of preclinical research in HT are provided.

Original languageEnglish (US)
Pages (from-to)322-327
Number of pages6
JournalTranslational Stroke Research
Volume4
Issue number3
DOIs
StatePublished - Jun 1 2013

Fingerprint

Stroke
Research
Reperfusion
Publications
Mortality
Therapeutics

Keywords

  • Animal models
  • Hemorrhagic infarction
  • Hemorrhagic transformation
  • Ischemic stroke
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Fagan, S. C., Lapchak, P. A., Liebeskind, D. S., Ishrat, T., & Ergul, A. (2013). Recommendations for Preclinical Research in Hemorrhagic Transformation. Translational Stroke Research, 4(3), 322-327. https://doi.org/10.1007/s12975-012-0222-5

Recommendations for Preclinical Research in Hemorrhagic Transformation. / Fagan, Susan C.; Lapchak, Paul A.; Liebeskind, David S.; Ishrat, Tauheed; Ergul, Adviye.

In: Translational Stroke Research, Vol. 4, No. 3, 01.06.2013, p. 322-327.

Research output: Contribution to journalReview article

Fagan, SC, Lapchak, PA, Liebeskind, DS, Ishrat, T & Ergul, A 2013, 'Recommendations for Preclinical Research in Hemorrhagic Transformation', Translational Stroke Research, vol. 4, no. 3, pp. 322-327. https://doi.org/10.1007/s12975-012-0222-5
Fagan, Susan C. ; Lapchak, Paul A. ; Liebeskind, David S. ; Ishrat, Tauheed ; Ergul, Adviye. / Recommendations for Preclinical Research in Hemorrhagic Transformation. In: Translational Stroke Research. 2013 ; Vol. 4, No. 3. pp. 322-327.
@article{d048c98a7fbb45d8a41936d448353010,
title = "Recommendations for Preclinical Research in Hemorrhagic Transformation",
abstract = "Hemorrhagic transformation (HT) is an important complication of ischemic stroke and is responsible for most of the mortality associated with acute reperfusion therapy. Although many important publications address the preclinical models of ischemic stroke, there are no current recommendations on the conduct of research aimed at understanding the mechanisms and consequences of HT. The purpose of this review is to present the various models used in HT research, the clinical correlates, and the experimental variables known to influence the quantitation of HT in preclinical investigation. Lastly, recommendations for the conduct of preclinical research in HT are provided.",
keywords = "Animal models, Hemorrhagic infarction, Hemorrhagic transformation, Ischemic stroke, Tissue plasminogen activator",
author = "Fagan, {Susan C.} and Lapchak, {Paul A.} and Liebeskind, {David S.} and Tauheed Ishrat and Adviye Ergul",
year = "2013",
month = "6",
day = "1",
doi = "10.1007/s12975-012-0222-5",
language = "English (US)",
volume = "4",
pages = "322--327",
journal = "Translational Stroke Research",
issn = "1868-4483",
publisher = "Springer US",
number = "3",

}

TY - JOUR

T1 - Recommendations for Preclinical Research in Hemorrhagic Transformation

AU - Fagan, Susan C.

AU - Lapchak, Paul A.

AU - Liebeskind, David S.

AU - Ishrat, Tauheed

AU - Ergul, Adviye

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Hemorrhagic transformation (HT) is an important complication of ischemic stroke and is responsible for most of the mortality associated with acute reperfusion therapy. Although many important publications address the preclinical models of ischemic stroke, there are no current recommendations on the conduct of research aimed at understanding the mechanisms and consequences of HT. The purpose of this review is to present the various models used in HT research, the clinical correlates, and the experimental variables known to influence the quantitation of HT in preclinical investigation. Lastly, recommendations for the conduct of preclinical research in HT are provided.

AB - Hemorrhagic transformation (HT) is an important complication of ischemic stroke and is responsible for most of the mortality associated with acute reperfusion therapy. Although many important publications address the preclinical models of ischemic stroke, there are no current recommendations on the conduct of research aimed at understanding the mechanisms and consequences of HT. The purpose of this review is to present the various models used in HT research, the clinical correlates, and the experimental variables known to influence the quantitation of HT in preclinical investigation. Lastly, recommendations for the conduct of preclinical research in HT are provided.

KW - Animal models

KW - Hemorrhagic infarction

KW - Hemorrhagic transformation

KW - Ischemic stroke

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84877137632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877137632&partnerID=8YFLogxK

U2 - 10.1007/s12975-012-0222-5

DO - 10.1007/s12975-012-0222-5

M3 - Review article

C2 - 23730351

AN - SCOPUS:84877137632

VL - 4

SP - 322

EP - 327

JO - Translational Stroke Research

JF - Translational Stroke Research

SN - 1868-4483

IS - 3

ER -